Dwight H. Egan

All filings by Dwight H. Egan on record concern Co-Diagnostics, Inc., in the capacity of chief executive. Over a trading history stretching from 24 May 2021 to 23 May 2026, the count stands at 13 filings.

The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

The latest filing, published on 27 May 2026, reports a transaction of €7,124 in Co-Diagnostics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.